AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

.alpha.-Diethylamino-2,6-acetoxylidide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 19 USDMF, 6 CEP/COS, 5 JDMF, 10 EU WC, 8 KDMF, 24 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

264 FDF Dossiers, 52 FDA Orange Book, 121 Europe, 19 Canada, 3 Australia, 14 South Africa, 55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, PATCH;TOPICAL - 5%, PATCH;TOPICAL - 70MG;70MG, CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Evonik, 3 Rochem International Inc, 12 SPI Pharma, 19 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 9 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Kewpie Corporation, 23 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 17 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 52 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 3 Clariant, 13 Corel Pharma Chem, 1 DFE Pharma, 3 Doshion Polyscience, 5 Finar, 18 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 11 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 8 Lubrizol Life Science Health, 17 Microlex e.U, 4 Nanjing Bold Chemical, 3 Nippon Fine Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 19 Roquette, 16 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 1 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Topical, 73 Solubilizers, 56 Fillers, Diluents & Binders, 50 Thickeners and Stabilizers, 41 Parenteral, 34 Emulsifying Agents, 33 Coating Systems & Additives, 29 Direct Compression, 28 Disintegrants & Superdisintegrants, 28 Film Formers & Plasticizers, 25 Granulation, 25 Lubricants & Glidants, 21 Surfactant & Foaming Agents, 19 Controlled & Modified Release, 18 Taste Masking, 16 Co-Processed Excipients, 13 Rheology Modifiers, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 6 API Stability Enhancers, 2 Coloring Agents, 1 Dry Powder Inhalation, 1 Soft Gelatin

DIGITAL CONTENT

107 News #PharmaBuzz

107 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 78 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

31 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 15 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
24/02/2025	Sanofi	France	SANOFI PHARMACEUTICALS INC	2801	LIDOCAINE HCL	1976-11-08	Inactive	II	N/A
24/02/2025	Moehs Iberica	Spain	MOEHS IBERICA SL	13235	LIDOCAINE	1998-09-25	Active	II	Complete	2013-03-15	2013-02-28

.alpha.-Diethylamino-2,6-acetoxylidide

.alpha.-Diethylamino-2,6-acetoxylidide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

19 USDMF

6 CEP/COS

5 JDMF

10 EU WC

8 KDMF

24 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

264 FDF Dossiers

52 FDA Orange Book

121 Europe

19 Canada

3 Australia

14 South Africa

55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

PATCH;TOPICAL - 5%

PATCH;TOPICAL - 70MG;70MG

CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Evonik

3 Rochem International Inc

12 SPI Pharma

19 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

6 Faran Shimi Pharmaceutical

9 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Kewpie Corporation

23 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

17 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

52 BASF

1 Bioplus Life Sciences

1 BioSpectra

3 Clariant

13 Corel Pharma Chem

1 DFE Pharma

3 Doshion Polyscience

5 Finar

18 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

2 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

11 Kerry

1 Kima Chemical

3 Lonza Capsugel

8 Lubrizol Life Science Health

17 Microlex e.U

4 Nanjing Bold Chemical

3 Nippon Fine Chemical

2 Nomisma Healthcare

4 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qualicaps

19 Roquette

CREAM;TOPICAL - 2.5%;2.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons